REMEDIUMREMEDIUM1561-59362658-3534Joint-Stock Company Chicot124010.21518/1561-5936-2018-5-30-32Original ArticleRussian pharmaceutical market at the first quarter-end 2018DenisovaMarianoemail@neicon.ruProzerinaJulianoemail@neicon.ruIQVIARemedium051220185303218032022Copyright © 2018,2018In 2017 and early 2018, the Russian market showed a stable situation and a slow recovery to the previous (pre-crisis) level. The economic crisis, the policy of import substitution, new legislative initiatives, and the introduction of drug labelling (DL) - to name a few from the list of factors that influence the current situation in the Russia's pharmaceutical industry. And while it is still too early to judge what the 2018 pharmaceutical market will be like for the domestic pharma market, the first quarter results have already demonstrated the key trends.Russian pharmaceutical marketcorporationsdrugsconsumptionsalesроссийский фармацевтический рыноккорпорациипрепаратыпотреблениепродажи